Invention Grant
- Patent Title: Macrocyclic hepatitis C serine protease inhibitors
- Patent Title (中): 大环丙型肝炎丝氨酸蛋白酶抑制剂
-
Application No.: US13339440Application Date: 2011-12-29
-
Publication No.: US08937041B2Publication Date: 2015-01-20
- Inventor: Keith F. McDaniel , Hui-Ju Chen , Ming Yeung , Timothy Middleton , Liangjun Lu , Kevin Kurtz
- Applicant: Keith F. McDaniel , Hui-Ju Chen , Ming Yeung , Timothy Middleton , Liangjun Lu , Kevin Kurtz
- Applicant Address: US IL North Chicago
- Assignee: AbbVie, Inc.
- Current Assignee: AbbVie, Inc.
- Current Assignee Address: US IL North Chicago
- Agency: Edwards Wildman Palmer LLP
- Agent Jeffrey D. Hsi; Stephen W. Rafferty
- Main IPC: A61K38/00
- IPC: A61K38/00 ; C07K5/08 ; C07K5/083
Abstract:
The present invention relates to novel fluorinated macrocyclic compounds and methods of treating a hepatitis C infection in a subject in need of such therapy with said macrocyclic compounds. The present invention further relates to pharmaceutical compositions comprising the compounds of the present invention, or pharmaceutically acceptable salts, esters, or prodrugs thereof, in combination with a pharmaceutically acceptable carrier or excipient.
Public/Granted literature
- US20120172291A1 MACROCYCLIC HEPATITIS C SERINE PROTEASE INHIBITORS Public/Granted day:2012-07-05
Information query
IPC分类:
